Cover Image
Market Research Report
Product code 
969646

Global Hepatitis B Vaccines Market 2020-2024

Published: | TechNavio (Infiniti Research Ltd.) | 120 Pages | Delivery time: 1-2 business days

Price

Back to Top
Global Hepatitis B Vaccines Market 2020-2024
Published: October 1, 2020
TechNavio (Infiniti Research Ltd.)
Content info: 120 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents

Technavio has been monitoring the hepatitis b vaccines market and it is poised to grow by $ 524.00 mn during 2020-2024, progressing at a CAGR of 4% during the forecast period. Our reports on the hepatitis B vaccines market provide a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high prevalence of hepatitis B globally, rising initiatives to increase awareness about hepatitis B, and increasing funding for the development of vaccines. In addition, the high prevalence of hepatitis B globally is anticipated to boost the growth of the market as well.

The hepatitis B vaccines market analysis includes end-user segment, type segment, and geographical landscapes.

Technavio's ‘hepatitis b vaccines market ’ is segmented as below:

By End-user:

  • Adult
  • Pediatric

By Type:

  • Mono Vaccines
  • Combination Vaccines

By Geographic Landscape:

  • North America
  • Europe
  • Asia
  • ROW

This study identifies the rising awareness of immunization in low- and middle-income countries as one of the prime reasons driving the hepatitis B vaccine market growth during the next few years. Also, new technological advancements and a strong pipeline will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the hepatitis b vaccines market covers the following areas:

  • Hepatitis b vaccines market sizing
  • Hepatitis b vaccines market forecast
  • Hepatitis b vaccines market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading hepatitis B vaccines market vendors that include Bharat Biotech Ltd., Dynavax Technologies Corp., GlaxoSmithKline Plc, Indian Immunologicals Ltd., KM Biologics Co. Ltd., LG Chem Ltd., Merck & Co. Inc., Sanofi, Serum Institute of India Pvt. Ltd., and Shenzhen Kangtai Biological Products Co. Ltd. Also, the hepatitis B vaccines market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Product Code: IRTNTR45291

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by End-user

  • Market segments
  • Comparison by End-user
  • Adult - Market size and forecast 2019-2024
  • Pediatric - Market size and forecast 2019-2024
  • Market opportunity by End-user

Market Segmentation by Type

  • Mono vaccines
  • Combination vaccines

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Bharat Biotech Ltd.
  • Dynavax Technologies Corp.
  • GlaxoSmithKline Plc
  • Indian Immunologicals Ltd.
  • KM Biologics Co. Ltd.
  • LG Chem Ltd.
  • Merck & Co. Inc.
  • Sanofi
  • Serum Institute of India Pvt. Ltd.
  • Shenzhen Kangtai Biological Products Co. Ltd.

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

Exhibit

  • 1: Key Finding 1
  • 2: Key Finding 2
  • 3: Key Finding 3
  • 4: Key Finding 5
  • 5: Key Finding 6
  • 6: Key Finding 7
  • 7: Key Finding 8
  • 8: Parent market
  • 9: Market characteristics
  • 10: Offerings of vendors included in the market definition
  • 11: Market segments
  • 12: Global - Market size and forecast 2019 - 2024 ($ million)
  • 13: Global market: Year-over-year growth 2019 - 2024 (%)
  • 14: Five forces analysis 2019 & 2024
  • 15: Bargaining power of buyers
  • 16: Bargaining power of suppliers
  • 17: Threat of new entrants
  • 18: Threat of substitutes
  • 19: Threat of rivalry
  • 20: Market condition - Five forces 2019
  • 21: End user - Market share 2019-2024 (%)
  • 22: Comparison by End user
  • 23: Adult - Market size and forecast 2019-2024 ($ million)
  • 24: Adult - Year-over-year growth 2019-2024 (%)
  • 25: Pediatric - Market size and forecast 2019-2024 ($ million)
  • 26: Pediatric - Year-over-year growth 2019-2024 (%)
  • 27: Market opportunity by End user
  • 28: Customer landscape
  • 29: Market share by geography 2019-2024 (%)
  • 30: Geographic comparison
  • 31: North America - Market size and forecast 2019-2024 ($ million)
  • 32: North America - Year-over-year growth 2019-2024 (%)
  • 33: Europe - Market size and forecast 2019-2024 ($ million)
  • 34: Europe - Year-over-year growth 2019-2024 (%)
  • 35: Asia - Market size and forecast 2019-2024 ($ million)
  • 36: Asia - Year-over-year growth 2019-2024 (%)
  • 37: ROW - Market size and forecast 2019-2024 ($ million)
  • 38: ROW - Year-over-year growth 2019-2024 (%)
  • 39: Key leading countries
  • 40: Market opportunity by geography ($ million)
  • 41: Impact of drivers and challenges
  • 42: Vendor landscape
  • 43: Landscape disruption
  • 44: Industry risks
  • 45: Vendors covered
  • 46: Market positioning of vendors
  • 47: Bharat Biotech Ltd. - Overview
  • 48: Bharat Biotech Ltd. - Product and service
  • 49: Bharat Biotech Ltd. - Key offerings
  • 50: Bharat Biotech Ltd. - Key customers
  • 51: Bharat Biotech Ltd. - Segment focus
  • 52: Dynavax Technologies Corp. - Overview
  • 53: Dynavax Technologies Corp. - Business segments
  • 54: Dynavax Technologies Corp. - Key offerings
  • 55: Dynavax Technologies Corp. - Key customers
  • 56: Dynavax Technologies Corp. - Segment focus
  • 57: GlaxoSmithKline Plc - Overview
  • 58: GlaxoSmithKline Plc - Business segments
  • 59: GlaxoSmithKline Plc - Key offerings
  • 60: GlaxoSmithKline Plc - Key customers
  • 61: GlaxoSmithKline Plc - Segment focus
  • 62: Indian Immunologicals Ltd. - Overview
  • 63: Indian Immunologicals Ltd. - Product and service
  • 64: Indian Immunologicals Ltd. - Key offerings
  • 65: Indian Immunologicals Ltd. - Key customers
  • 66: Indian Immunologicals Ltd. - Segment focus
  • 67: KM Biologics Co. Ltd. - Overview
  • 68: KM Biologics Co. Ltd. - Product and service
  • 69: KM Biologics Co. Ltd. - Key offerings
  • 70: KM Biologics Co. Ltd. - Key customers
  • 71: KM Biologics Co. Ltd. - Segment focus
  • 72: LG Chem Ltd. - Overview
  • 73: LG Chem Ltd. - Business segments
  • 74: LG Chem Ltd. - Key offerings
  • 75: LG Chem Ltd. - Key customers
  • 76: LG Chem Ltd. - Segment focus
  • 77: Merck & Co. Inc. - Overview
  • 78: Merck & Co. Inc. - Business segments
  • 79: Merck & Co. Inc. - Key offerings
  • 80: Merck & Co. Inc. - Key customers
  • 81: Merck & Co. Inc. - Segment focus
  • 82: Sanofi - Overview
  • 83: Sanofi - Business segments
  • 84: Sanofi - Key offerings
  • 85: Sanofi - Key customers
  • 86: Sanofi - Segment focus
  • 87: Serum Institute of India Pvt. Ltd. - Overview
  • 88: Serum Institute of India Pvt. Ltd. - Product and service
  • 89: Serum Institute of India Pvt. Ltd. - Key offerings
  • 90: Serum Institute of India Pvt. Ltd. - Key customers
  • 91: Serum Institute of India Pvt. Ltd. - Segment focus
  • 92: Shenzhen Kangtai Biological Products Co. Ltd. - Overview
  • 93: Shenzhen Kangtai Biological Products Co. Ltd. - Product and service
  • 94: Shenzhen Kangtai Biological Products Co. Ltd. - Key offerings
  • 95: Shenzhen Kangtai Biological Products Co. Ltd. - Key customers
  • 96: Shenzhen Kangtai Biological Products Co. Ltd. - Segment focus
  • 97: Currency conversion rates for US$
  • 98: Research Methodology
  • 99: Validation techniques employed for market sizing
  • 100: Information sources
  • 101: List of abbreviations